67,000.00 - 90,000.00 / box
| Business Type | Exporter, Supplier |
| Strength | 40 mg |
| Form | Liquid |
| Type | Allopathic |
| Click to view more | |
Product Details
Country of Origin
USA
Generic Name
Danyelza
Composition
Naxitamab
Storage
Cool & Dry Place
Danyelza is used, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat pediatric patients aged 1 year and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have a partial response, minor response, or stable disease to prior therapy.
Looking for "Danyelza Injection" ?
Piece
Explore More Products
